USE OF A FUNCTIONAL CLASSIFICATION OF ANEMIA IN MYELODYSPLASTIC SYNDROMES TO IDENTIFY SUBGROUPS OF PATIENTS RESPONSIVE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
A. Bucalossi et al., USE OF A FUNCTIONAL CLASSIFICATION OF ANEMIA IN MYELODYSPLASTIC SYNDROMES TO IDENTIFY SUBGROUPS OF PATIENTS RESPONSIVE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY, European journal of haematology, 56(1-2), 1996, pp. 106-108